Reviewer Acknowledgement for 2024

Peer review is a cornerstone of scientific research, ensuring academic quality and advancing progress. Reviewers play a vital role in evaluating the scientific merit, rigor, and relevance of scholarly work, helping to uphold the high quality of publication.

For Cancer Drug Resistance (CDR), the contributions of our reviewers have been invaluable. They help identify high-quality research, provide constructive feedback to authors, and contribute to continuous improvement.

We sincerely thank all the reviewers for their dedication and expertise over the past year. Your thorough evaluations have been essential to CDR’s growth and our ability to advance cancer drug resistance research at the forefront of the field. The following is a list of our reviewers:

As Cancer Drug Resistance embarks on a new year, we remain committed to maintaining the high publication standards that define our journal. Our mission is to continue promoting advancements in cancer drug resistance research.

Reviewers are vital to our success, and we look forward to further strengthening our collaboration with current reviewers. We also warmly welcome new members to join our team, volunteering as reviewers and submitting your scholarly work to Cancer Drug Resistance. Your expertise is essential in making a meaningful difference.

Editor: Lori Hu
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Cancer Drug Resistance